# Galderma

Source: https://onco.cc/companies/galderma/  
OnCo record `galderma` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Galderma is a Swiss dermatology company, listed in 2024, whose cancer-related trials concern photodynamic therapy for actinic keratosis and basal cell carcinoma.

## Summary

Galderma, based in Zug and listed on the SIX Swiss Exchange since 2024, is a dermatology company spanning prescription medicines, aesthetics and consumer skin care. Its cancer-related registry trials mostly concern methyl aminolevulinate photodynamic therapy (Metvix) for actinic keratosis and superficial basal cell carcinoma. OnCo records it so that those phase 3 trials resolve to a sponsor page.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Galderma R&D; Galderma S.A.
- Tags: ctgov-sponsor
- HQ: Zug
- Type: pharma
- Website: https://www.galderma.com

## Sources

- Official website: https://www.galderma.com
- ClinicalTrials.gov: trials led by Galderma: https://clinicaltrials.gov/search?lead=Galderma
- Wikipedia: https://en.wikipedia.org/wiki/Galderma

## Connected records

- cancers: [Basal cell carcinoma](https://onco.cc/cancers/basal-cell-carcinoma/), [Cutaneous squamous cell carcinoma](https://onco.cc/cancers/cutaneous-scc/)
- fronts: [Prevention & Risk](https://onco.cc/fronts/prevention/)

---
JSON: https://onco.cc/api/v1/entities/galderma.json